Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Illumina Laboratory Services, |
RCV000779338 | SCV000915930 | likely pathogenic | Mitochondrial DNA depletion syndrome 9 | 2018-11-01 | criteria provided, single submitter | clinical testing | The SUCLG1 c.41T>C (p.Met14Thr) variant has been reported in a homozygous state in two individuals from a consanguineous family with mitochondrial encephalopathy and lactic acidosis and in a compound heterozygous state with another missense variant in one individual with fatal infantile lactic acidosis in a compound heterozygous (Sakamoto et al. 2011; Maalej et al. 2018). In both families, parents were heterozygous carriers. A third individual with fatal infantile lactic acidosis was found with another variant in a homozygous state that causes the same p.Met14Thr alteration (Van Hove et al. 2010). The p.Met14Thr variant was absent from 200 control chromosomes. Frequency information for this variant is not available in the 1000 Genomes database, the Exome Sequencing Project, the Exome Aggregation Consortium, or the Genome Aggregation Database. Functional assays using fibroblasts from the individual who was compound heterozygous for this variant demonstrated a reduction in the levels and activity of mitochondrial respiratory chain complex I. However, the ratios of mtDNA/nDNA of fibroblasts and muscle were similar to controls (Sakamoto et al. 2011). In blood leukocytes from the individuals homozygous for the p.Met14Thr variant, a reduction of mtDNA content was observed (89.49% for one proband and 47.62% for the other proband) (Maalej et al. 2018). Based on the evidence, the p.Met14Thr variant is classified as likely pathogenic for SUCLG1-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. |